The influence of Isorel on the advanced colorectal cancer

Cancer Biotherapy and Radiopharmaceuticals

Volumn 18, Issue 1, 2003, Pages 27-34

  Cazacu, Mircea ^a,f   Oniu, Traian ^a   Lungoci, Cornel ^a   Mihailov, Anca ^b   Cipak, Ana ^c   Klinger, Rainer ^d   Weiss, Thomas ^e   Zarkovic, Neven ^c  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Administration in Cluj Napoca   (Romania)

^c RUDER BO KOVI INSTITUTE   (Croatia)

^d Biomedica GmbH   (Austria)

^e Novipharm GmbH   (Austria)

^f IVth Surgical Clinic   (Romania)

Author keywords

Biotherapy; Cancer; Colon carcinoma; Lectins; Mistletoe; MTT bioassay; Viscum album

Indexed keywords

FLUOROURACIL; VISCUM ALBUM EXTRACT;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MISTLETOE; PHYTOTHERAPY; PLANT EXTRACTS; SURVIVAL RATE;

EID: 0037219287     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497803321269304     Document Type: Article

References (58)

1. Steiner R. Spiritual sciences and medicine. Rudolf Steiner Publishing Co., London, 1920.
2. Kanner L. Mistletoe, magic and medicine. Bull Hist Med 1939;7:875-883.
3. Khwaja TA, Dias CB, Pentecost S, Papoian H. Studies on cytotoxic and immunologic effects of Viscum album (mistletoe). Proc Am Ass Cancer Res 1981;22:153-162.
4. Franz H. Request for an impartial discussion of the so-called mistletoe therapy. Oncology 1986;43(suppl. 1):1-15.
5. Kissel D, Jurin M, Žarković N. Über die kombinierte Tumortherapie: Eine experimen-telle studie über die wirksamkeit von Viscum album. Dtch Zscg Onkol 1990;22:134-136.
6. Kleijnen J, Knipschild P. Mistletoe treatment for cancer: review of controlled trials in humans. Phytomedicine 1994;1:255-260.
7. Büssing A. Mistletoe: A story with an open end. Anti Cancer Drugs 1997;8(suppl. 1):1-2.
8. Klamerth O, Vester F, Kellner G. Inhibitory effects of a protein complex from Viscum album on fibroblasts and HeLa cells. Hoppe-Seyle's Z. physio Chem 1968;349:863-870.
9. Jung ML, Baudino S, Ribereau-Gayon G, Beck JP. Characterization of cytotoxic proteins from mistletoe (Viscum album L.). Cancer Lett 1990;51:103-114.
10. Samuelsson G Mistletoe toxins. Syst Zool 1974;22:566-571.
11. Hulsen H, Mechelke F. In vitro effectiveness of a mistletoe preparation on cytostatic-drug-resistant human leukemia cells. Naturwiss 1987;74:144-152.
12. Kissel D, Jurin M, Žarković N. Uber die zytostatischen und immunologishen effecte von Viscum album. Erfahrungscheilkunde 1990;39:59-63.
13. Jurin M, Žarković N, Hrženjak M, Ilić Z. Antitumorous and immunomodulatory effects of Viscum album preparation Isorel. Oncology 1993;50:393-398.
14. Hulsen H, Kron R, Mechelke F. Influence of Viscum album preparation on the natural killer cell-mediated cytotoxicity of peripheral blood. Naturwiss 1989;76:530-535.
15. Hajto T, Hostanska K, Gabius HJ. Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res 1989;49:4803-4814.
16. Männel DN, Becker H, Gundt A, Kist A, Franz H. Induction of tumor necrosis factor expression by lectin from Viscum album. Cancer Immunol Immunother 1991;33:177-184.
17. Ganguly C, Das S. Plant lectins as inhibitors of tumor growth and modulators of host immune response. Chemotherapy 1994;40:272-278.
18. Beuth J, Ko HL, Tunggal L, Buss G, Jeljasewitz J, Steur MK, Pulverer G. Immunoaktive wirkung von Mistellektin-I in abhangigkeit von Dosierung. Arznem.-Forsch./Drug Res 1994;44:21-25.
19. Olsems S, Stripe F, Sandevig K, Phil A. Isolation and characterization of viscumin, a toxic lectin from Viscum album L. (mistletoe). J Biol Chem 1982;257:1326-1334.
20. Heiny BM, Beuth J. Mistletoe extract standardized for the galactoside-specific lectin (ML-I) induces beta-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res 1994;14:1339-1342.
21. Beuth J. Clinical relevance of immunoactive mistletoe lectin-1. Anti-Cancer Drugs 1997;8(suppl 1):53-56.
22. Khwaja TA, Varven JC, Pentecost S, Pande H. Isolation of biologically active alkaloids from Korean mistletoe Viscum album coloratum. Experientia 1980;36:599-605.
23. Konopa J, Woyranowski JM, Lewandowska-Gumieniak M. Isolation of viscotoxins, cytotoxic basic peptides from Viscum album L. Hoppe-Seyler's Z Physiol Chem 1980;361:1525-1535.
24. Kuttan G, Vasudevan DM, Kuttan R. Isolation and identification of a tumor reducing components from mistletoe extract (Iscador). Cancer Lett 1988;4:307-314.
25. Klett CY, Anderer FA. Activation of natural killer cell: cytotoxicity of human blood monocytes by a low molecular weight component from Viscum album extract. Drug Res 1989;39:1580-1586.
26. Stein G, Berg PA. Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro. E J Clin Pharm 1994;47:33-38.
27. Žarković N, Trbojević-Čepe M, Ilić Z, Hrženjak M, Grainca S, Jurin M. Comparison of the effects of high and low concentrations of the separated Viscum album L. lectins and of the plain mistletoe plant preparation (Isorel) on the growth of normal and tumor cells in vitro. Period biol 1995;97:61-67.
28. Büssing A, Jurin M, Zarkovic N, Azahari T, Schweizer K. DNA - stabilisierende wirkungen von Viscum album L. - Sind mistelextrakte, als adjuvans wärend der koventionellen chemotherapie indiziert? Forsch Komplementärmed, 1997;3:244-248.
29. Zarkovic N, Vukovic T, Loncaric I, Miletic M, Zarkovic K, Borovic S, Cipak A, Sabolovic S, Konitzer M and Mang S. An overview on anticancer activities of the Viscum album extract Isorel. Cancer Biother Radiopharm 2001;16:55-62.
30. Bussing A, Schaller G, Pfuller U. Generation of reactive oxygen intermediates (ROI) by the thionins from Viscum album L. Anticancer Res 1998;18:4291-4296.
31. Cazacu M, Mihailov A, Toganel E, Lungoci C, Oniu T. The immunotherapy with Isorel modifies the immunological profile and survival in patients operated on for colorectal cancers. Radioter Oncol Med 2002;1:49-53.
32. Žarković N, Kalisnik T, Loncarić I, Borovic S, Mang S, Kissel D, Konitzer M, Jurin M, Grainza S. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10. Cancer Biother Radiopharm 1998;13:121-131.
33. Slater TF, Sawyer B, Sträuli U. Studies on succinatetetrazolium reductase systems:points of coupling of four different tetrazolium salts. Biochim Biophys Acta 1963;77:383-393.
34. Carmichael J, De Graff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987;47:936-942.
35. th Edition; Lippincott Williams & Wilkins 2001;33:33-37.
36. Beuth J. Clinical relevance of immunoactive mistletoe lectin-I. Anticancer Drugs 1997;8 Suppl 1:S53-55.
37. Kubasova T, Petcu I, Pfuller U, Koteles GJ. Effects of mistletoe lectin I and ionizing radiation on the glucose and thymidine uptake in tumour cells in vitro. Phytother Res 1999;13:655-659.
38. Bantel H, Engels IH, Voelter W, Schulze-Osthoff K, Wesselborg S. Mistletoe lectin activates caspase-8/ FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res 1999;59:2083-2090.
39. Kim MS, Lee J, So HS, et al. Gamma-interferon (IFN-gamma) augments apoptotic response to mistletoe lectin-II via upregulation of Fas/Fas L expression and caspase activation in human myeloid U937 cells. Immunopharmacol Immunotoxicol 2001;23:55-66.
40. Zarkovic N, Zarkovic K, Grainca S, Kissel D, Jurin M. The Viscum album preparation Isorel inhibits the growth of melanoma B16F10 by influencing the tumour-host relationship. Anticancer Drugs 1997;8 Suppl 1:S17-22.
41. Vervecken W, Kleff S, Pfüller U, Bussing A. Induction of apoptosis by mistletoe lectin I and its subunits. No evidence for cytotoxic effects caused by isolated A- and B-chains. Int J Biochem Cell Biol 2000;32:317-326.
42. Pae HO, Seo WG, Oh GS, et al. Potentiation of tumor necrosis factor-alpha-induced apoptosis by mistletoe lectin. Immunopharmacol Immunotoxicol 2000;22:697-709.
43. Bussing A, Multani AS, Pathak S, Pfuller U, Schietzel M. Induction of apoptosis by the N-acetyl-galactosamine-specific toxic lectin from Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and induction of telomeric associations. Cancer Lett 1998;130(1-2):57-68.
44. Yoon TJ, Yoo YC, Kang TB, et al. Lectins isolated from Korean mistletoe (Viscum album coloratum) induce apoptosis in tumor cells. Cancer Lett 1999;136(1):33-40.
45. Bussing A, Schaller G, Pfuller U. Generation of reactive oxygen intermediates (ROI) by the thionins from Viscum album L. Anticancer Res 1998;18(6A):4291-4296.
46. Bussing A, Wagner M, Wagner B, Stein GM, Schietzel M, Schaller G, Pfuller U. Induction of mitochondrial Apo2.7 molecules and generation of reactive oxygen-intermediates in cultured lymphocytes by the toxic proteins from Viscum album L. Cancer Lett 1999;139(1):79-88.
47. Braun JM, Ko HL, Schierholz JM, Weir D, Blackwell CC, Beuth J. Application of standardized mistletoe extracts augment immune response and down regulates metastatic organ colonization in murine models. Cancer Lett 2001;170:25-31.
48. Yoon TJ, Yoo YC, Kang TB, Baek YJ, Huh CS, Song SK, Lee KH, Azuma I, Kim JB. Prophylactic effect of Korean mistletoe (Viscum album coloratum) extract on tumor metastasis is mediated by enhancement of NK cell activity. Int J Immunopharmacol 1998;20(4-5):163-172.
49. Zarkovic N, Jurin M, Dittrich W, Hartleb M, Sladoljev S, Kissel D. Comparison of the antitumorous effects of Viscum album lectins and the plain or fractional fresh plant preparation Isorel. In: (Scheer R, ed.) Grundlagen der Misteltherapie, Hippocrates Verlag, Stuttgart, 1996:325-336.
50. Elsässer-Beile U, Voss M, Schühle R, Wetterauer U. Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitro. J Clin Lab Anal 2000;14:255-259.
51. Fischer S, Scheffler A, Kabelitz D. Stimulation of the specific immune system by mistletoe extracts. Anticancer Drugs 1997;8 Suppl 1:S33-37.
52. Mengs U, Witthohn K, Schwarz T, Lentzen H. Value of mistletoe lectin standardized mistletoe extract for evaluating antitumor properties. Wien Med Wochenschr 1999;149:262-264.
53. Boneberg EM, Hartung T. Mistletoe lectin-1 increases tumor necrosis factor-alpha release in lipopolysaccharide-stimulated whole blood via inhibition of interleukin-10 production. J Pharmacol Exp Ther 2001;298:996-1000.
54. Stein GM, Berg PA. Modulation of cellular and humoral immune responses during exposure of healthy individuals to an aqueous mistletoe extract. Eur J Med Res 1998;3:307-314.
55. Hajto T, Hostanska K, Weber K, Zinke H, Fischer J, Mengs U, Lentzen H, Saller R. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo. Nat Immun 1998;16(1):34-46.
56. Elsasser-Beile U, Lusebrink S, Grussenmeyer T, Wetterauer U, Schultze-Seemann W. Comparison of the effects of various clinically applied mistletoe preparations on peripheral blood leukocytes. Arzneimittelforschung 1998;48(12):1185-1189.
57. Heiny BM, Albrecht V, Beuth J. Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract. Anticancer Res 1998;18(1B):583-586.
58. Gray AM, Flatt PR. Insulin-secreting activity of the traditional antidiabetic plant Viscum album (mistletoe). J Endocrinol 1999;160:409-414.